Targeted News Service logo

-- Preview Email Newsletter
*Illinois Editor Tipoffs Newsletter for 2025-10-20 ( 4 items )  
ACOEM Urges Rescission of COVID-19 Recordkeeping Requirements (10)
WASHINGTON, Oct. 20 -- The American College of Occupational and Environmental Medicine (ACOEM), Elk Grove Village, Illinois, has submitted a public comment letter to the U.S. Department of Labor's Occupational Safety and Health Administration (OSHA) calling for the elimination of certain COVID-19 recordkeeping provisions. ACOEM represents over 3,000 health professionals dedicated to enhancing the safety and health of the workforce and asserts that the existing requirements are unnecessary and re more ST

Lake Land College Opposes Proposed Survey By Education Department (10)
WASHINGTON, Oct. 19 -- Jean Anne Highland, Chief of Staff at Lake Land College, Mattoon, Illinois, has submitted a public comment letter to the U.S. Department of Education expressing concerns over the proposed "Admissions and Consumer Transparency Supplement" survey. The Chief of Staff argues that the new data collection system could impose an undue burden on community colleges and their students. The Education Department's notice in the Federal Register sought input regarding whether open-enr more ST

NAICU Raises Concerns Over Proposed Data Collection Changes (10)
WASHINGTON, Oct. 20 -- The National Association of Independent Colleges and Universities, and 32 academic associations have submitted a public comment letter to the U.S. Department of Education outlining its apprehensions regarding proposed changes to the integrated postsecondary education data system (IPEDS), specifically focusing on the introduction of the Admissions and Consumer Transparency Supplement (ACTS). Representing over 1,700 private, nonprofit colleges and universities across the nat more ST

Plano Pharmaceuticals Advocates for Enhanced Drug Manufacturing Policies (10)
WASHINGTON, Oct. 19 -- Plano Pharmaceuticals Inc., Zion, Illinois, submitted a public comment letter to the U.S. Food and Drug Administration addressing key concerns related to the agency's initiative, "Onshoring Manufacturing of Drugs and Biological Products." The company, which was founded in 2023 and is currently establishing its first manufacturing facility in Illinois, supports the initiative aimed at boosting domestic drug production and enhancing public health. In the letter, Plano Pharm more ST